Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
Director
-
Issuer Symbol
-
APGE on Nasdaq
Fairmount Funds Management LLC - trading volume in the past year for Apogee Therapeutics, Inc.
Holdings reported by Fairmount Funds Management LLC for Apogee Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
298,647 |
$22,786,766 |
$76.30 |
22 Jan 2026 |
By Fairmount Healthcare Fund II LP |
|
|
| Common Stock |
51,166 |
$3,862,019 |
$75.48 |
22 Jan 2026 |
By Peter Harwin |
|
|
| Common Stock |
51,166 |
$3,862,019 |
$75.48 |
22 Jan 2026 |
By Tomas Kiselak |
|
|
| Stock Option (Right to Buy) |
14,461 |
|
|
17 Jun 2025 |
By: Peter Harwin |
Common Stock |
|
| Stock Option (Right to Buy) |
14,461 |
|
|
17 Jun 2025 |
By: Tomas Kiselak |
Common Stock |
|
Transactions reported by Fairmount Funds Management LLC for Apogee Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.